Best Oral 7
Pancreas 2

[BO7-2] Multicenter phase II study of adjuvant chemotherapy with 5-FU and heparin-based portal infusion chemotherapy followed by S-1 for patients with resected pancreatic cancer (TOSPAC-02)

^○Minoru Kitago¹, Koich Aiura², Keiichi Suzuki³, Masaya Shito², Sojun Hoshimoto², Junichi Matsui⁴, Yutaka Takigawa⁴, Masatsugu Ishii⁵, Hiroshi Yagi¹, Yuta Abe¹, Taizo Hibi¹, Kiminori Takano¹, Go Oshima¹, Yusuke Fujita¹, Syunichi Imai¹, Yutaka Nakano¹, Yuki Masuda¹, Yutaka Endo¹, Masahiro Shinoda¹, Osamu Itano¹, Yuko Kitagawa¹ (1.Department of Surgery, Keio University School of Medecine, Tokyo, Japan, 2.Department of Surgery, Kawasaki Municipal Hospital, Kawasaki, Japan, 3.Department of Surgery, Kitasato Institute Hospital, Tokyo, Japan, 4.Department of Surgery, Tokyo Dental College Ichikawa General Hospital, Tokyo, Japan, 5.Department of Surgery, Isehara Kyodo Hospital, Kanagawa, Japan)